Cargando…

SUN-LB093 Change in Bone Mineral Density over One Year Was Not Associated with FGF-23 in Patients New to Dialysis

Background: FGF-23 is a phosphaturic factor as it inhibits renal phosphate reabsorption and vitamin D activation. FGF - 23 levels are elevated in hemodialysis patients irrespective of serum phosphate levels. No association was found between FGF - 23 and cortical bone mineral density (BMD) in individ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Neil, Yang, Danwen, Rosas, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553234/ http://dx.doi.org/10.1210/js.2019-SUN-LB093

Ejemplares similares

SUN-LB090 Accounting for Skeletal Maturation in the Assessment of Pediatric Bone Mineral Density
por: McCormack, Shana, et al.
Publicado: (2019)

SAT-LB093 Salty Relationships with Bone: Not Calcium nor Vitamin D
por: Hew-Butler, Tamara, et al.
Publicado: (2019)

ODP093 Hunt for Hypercalcemia
por: Wang, Ally W, et al.
Publicado: (2022)

SUN-LB70 Bone Mineral Density, Vitamin D Status and Bone Turnover Markers in Thai Youth With Graves’ Disease: A Pilot Study
por: Wiromrat, Pattara, et al.
Publicado: (2020)

SUN-LB67 Revisit Serum Calcium Correction
por: Li, Yulong, et al.
Publicado: (2020)

SUN-LB64 Urine Phosphoethanolamine Is an Underutilized Biomarker for Hypophosphastasia
por: Shajani-Yi, Zahra, et al.
Publicado: (2020)

SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia
por: Gafni, Rachel Ilana, et al.
Publicado: (2020)

SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020)

SUN-345 Use of Anti-FGF23 Monoclonal Antibody in the Treatment of Children and Adolescents with X-Linked Hypophosphatemic Rickets
por: Cassinelli, Hamilton Raul, et al.
Publicado: (2020)

SUN-LB089 Mild Form of Childhood Hypophosphatasia: A Novel Mutation
por: Benzrihen, María, et al.
Publicado: (2019)

SUN-LB088 Octreotide Induced Hypocalcemia in Case of Familial Hypocalciuric Hypercalcemia
por: Alkhazaali, Ali, et al.
Publicado: (2019)

SAT-LB085 First Report of Burosumab (Anti-FGF23 Monoclonal Antibody) for Rickets Complicating HRAS-Associated Cutaneous Skeletal Hypophosphatemia Syndrome
por: Smith, Pamela, et al.
Publicado: (2019)

SUN-371 Hyponatremia Correction Normalizes Bone Mineral Density and Bone Fragility in Rats
por: Xu, Qin, et al.
Publicado: (2020)

SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
por: Jawahar, Abhinaya, et al.
Publicado: (2020)

SUN-LB73 Is It Possible to Optimize Resources in Bone-Alkaline Phosphatase Medical Request?
por: Sequera, Ana M, et al.
Publicado: (2020)

SUN-359 Antenatal Oral Iron Supplementation, FGF23 and Bone Metabolism in Kenyan Women and Their Offspring: A Randomised Controlled Trial
por: Braithwaite, Vickie S, et al.
Publicado: (2020)

SUN-342 Effect of Hyperglycemia on Bone Mineral Density and Fracture in Pre-Liver Transplant Recipients
por: Abate, Ejigayehu G, et al.
Publicado: (2020)

SUN-LB091 Impact of Albumin Corrected Calcium on the Prevalence and Categories of Hypercalcemia in Hospitalized Patients
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020)

SUN-396 Denosumab Preserves Bone Mineral Density at the Knee in Persons with Subacute Spinal Cord Injury
por: Bauman, William Alan, et al.
Publicado: (2020)

SUN-LB63 Optic Disc Edema in Patients With Craniofacial Fibrous Dysplasia / McCune-Albright
por: Raborn, Layne, et al.
Publicado: (2020)

MON-LB087 Synthesis of Osteocyte-Derived Phosphaturic Hormone FGF23 via IP3/PKC Signaling Downstream of the Extra-Large Gα Subunit (XLαs)
por: He, Qing, et al.
Publicado: (2019)

SAT-362 A Bone to Pick with FGF23
por: Soliman, Peter, et al.
Publicado: (2020)

SUN-LB092 The Role of the Modified Performance-Oriented Mobility Assessment Tool in the Evaluation of Gait in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2019)

SUN-LB74 Radiofrequency Echographic Multi-Spectrometry (REMS) for the Assessment of Bone Strength and Fracture Risk Prediction
por: Ciardo, Delia, et al.
Publicado: (2020)

SUN-348 Growth Hormone Replacement in Adults During 8 Years Leads to Sustained Increase in Bone Mineral Density
por: Payer, Juraj, et al.
Publicado: (2020)

SUN-LB65 Circulating Micrornas Linked to Bone Metabolism Are Affected by Sequential Anti Osteoporotic Treatment in Postmenopausal Osteoporosis
por: Yavropoulou, Maria, et al.
Publicado: (2020)

MON-502 It's Not Always Osteoporosis: FGF-23 Induced Osteomalacia
por: Bello Segura, Manuel, et al.
Publicado: (2019)

SUN-355 Associations of Trabecular Bone Score and Bone Mineral Density with Cardiorespiratory Fitness and Body Composition in Men with and Without Paraplegia
por: Usuga, Daniela, et al.
Publicado: (2020)

SUN-534 Effect of Cross-Sex Hormone Therapy on Body Composition, Visceral Adipose Tissue, and Bone Mineral Density in Transgender Men
por: Fighera, Tayane, et al.
Publicado: (2019)

SUN-LB085 Complicated Hungry Bone Syndrome Due to Tertiary Hyperparathyroidism in a Patient with Kidney Transplant: A Case to Remember
por: Jimenez-Zuluaga, Jose, et al.
Publicado: (2019)

SUN-LB68 Advanced Glycation Endproducts Are Associated With Worse Bone Material Strength in Older Adults With and Without Type 2 Diabetes
por: Samakkarnthai, Parinya, et al.
Publicado: (2020)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

Severe Hypophosphatemia and Elevated FGF23 Level Following Zoledronic Acid Infusion
por: Betlachin, Anna, et al.
Publicado: (2021)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Diagnostic Dilemma of Elevated FGF23 in a Patient With Osteomalacia: A Case Report
por: Bulut, Aysegul, et al.
Publicado: (2021)

SUN-LB087 Successful Prevention of Common Complications of Severe Hypercalcemia Secondary to Subcutaneous Fat Necrosis of the Newborn Following Whole Body Therapeutic Hypothermia
por: Ilaka-Chibuluzo, Sandra, et al.
Publicado: (2019)

MON-LB68 Dual Pathologic Mutations in SLC12A1 and GALNT3 Lead to Impaired Mineral Homeostasis
por: Shi, Melody, et al.
Publicado: (2020)

SAT-385 A Normal FGF23 Does Not Preclude Tumor Induced Osteomalacia (TIO)
por: Nandam, Neeharika, et al.
Publicado: (2020)

SUN-395 Pelvic Bone Density Is Lower Than Bone Density of Hip and Femoral Neck in Postmenopausal Women
por: Mohseni, Mahshid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37j6gm84p43qv0u08b122goljk